Acciones LexaGene Holdings Inc. Toronto S.E.
Acciones
LXG.H
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,06 % | 9411,02 M | |
-8,43 % | 3031,09 M | |
+27,31 % | 2896,27 M | |
-14,31 % | 2157,3 M | |
-18,94 % | 1704,79 M | |
+73,13 % | 1506,3 M | |
+30,25 % | 814 M | |
-1,97 % | 760 M | |
-26,73 % | 529 M |